Leprosy tertiary prevention

Jump to navigation Jump to search

Leprosy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Leprosy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Leprosy tertiary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Leprosy tertiary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Leprosy tertiary prevention

CDC on Leprosy tertiary prevention

Leprosy tertiary prevention in the news

Blogs on Leprosy tertiary prevention

Directions to Hospitals Treating Leprosy

Risk calculators and risk factors for Leprosy tertiary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Tertiary Prevention

Once an individual is infected with leprosy and symptoms start to develop, the longer the period to establish the correct diagnosis and treatment is started, greater the chance of developing lifetime damage to nerves, skin and body in general.

References


Template:WikiDoc Sources